Finance

Lists
21P:FRA
Aurora Cannabis Inc
₮3,52
-1,57%
(-0,056) 1D
30 āš.āš., 8 āŧ‚āšĄāš‡ 0 āš™āšēāš—āšĩ 45 āš§āšīāš™āšēāš—āšĩ GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 21P...
Open
₮3,52
High
₮3,52
Low
₮3,52
Mkt. cap
370,24 āšĨāŧ‰āšēāš™
Avg. vol.
3,32Â āšžāšąāš™
Volume
0,00
52-wk high
₮5,62
52-wk low
₮2,22
No. of employees
1Â āšžāšąāš™
Open
₮3,52
High
₮3,52
Low
₮3,52
Mkt. cap
370,24 āšĨāŧ‰āšēāš™
Avg. vol.
3,32Â āšžāšąāš™
Volume
0,00
52-wk high
₮5,62
52-wk low
₮2,22
No. of employees
1Â āšžāšąāš™
News stories
From web sources and news partners
Yahoo! Finance Canada
Yahoo! Finance Canada
·
12 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Curaleaf’s Takeover Bid for Aurora Cannabis: What Investors Need to Know
24/7 Wall St.
24/7 Wall St.
·
1 āŧ€āš”āš·āš­āš™āšāŧˆāš­āš™
Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here's Why TLRY Is Still Down 47% YTD
WSJ
WSJ
·
1 āŧ€āš”āš·āš­āš™āšāŧˆāš­āš™
Aurora Cannabis to Review Takeover Bid From Rival Curaleaf
Profile
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. The company began trading on the NYSE on October 23, 2018, using the ticker ACB. After significant expansion in 2018, the company reduced expenses in the second half of 2019 when the Canadian recreational cannabis market had low sales due to excessive inventory and uncompetitive pricing with the black market. In February 2020, cofounder and chief executive, Terry Booth, resigned, being replaced by Executive Chairman Michael Singer as interim CEO. Wikipedia
About Aurora Cannabis Inc
CEOMiguel Martin
Employees1,03Â āšžāšąāš™
Founded21 āš—.āš§. 2006
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
āš.āš. 2025
āš—.āš§. 2025
āšĄ.āš™. 2026
āšĄāšī.āš–. 2026
Revenue
90,37 āšĨāŧ‰āšēāš™
94,19 āšĨāŧ‰āšēāš™
38,01 āšĨāŧ‰āšēāš™
67,55 āšĨāŧ‰āšēāš™
Cost of goods sold
58,08 āšĨāŧ‰āšēāš™
47,57 āšĨāŧ‰āšēāš™
8,22 āšĨāŧ‰āšēāš™
31,93 āšĨāŧ‰āšēāš™
Cost of revenue
58,08 āšĨāŧ‰āšēāš™
47,57 āšĨāŧ‰āšēāš™
8,22 āšĨāŧ‰āšēāš™
31,93 āšĨāŧ‰āšēāš™
Research and development expenses
904,00Â āšžāšąāš™
1,30 āšĨāŧ‰āšēāš™
986,00Â āšžāšąāš™
941,00Â āšžāšąāš™
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
42,11 āšĨāŧ‰āšēāš™
41,06 āšĨāŧ‰āšēāš™
41,56 āšĨāŧ‰āšēāš™
41,78 āšĨāŧ‰āšēāš™
Operating expense
50,88 āšĨāŧ‰āšēāš™
44,44 āšĨāŧ‰āšēāš™
39,82 āšĨāŧ‰āšēāš™
44,35 āšĨāŧ‰āšēāš™
Total operating expenses
108,96 āšĨāŧ‰āšēāš™
92,01 āšĨāŧ‰āšēāš™
48,04 āšĨāŧ‰āšēāš™
76,28 āšĨāŧ‰āšēāš™
Operating income
-18,59 āšĨāŧ‰āšēāš™
2,18 āšĨāŧ‰āšēāš™
-10,03 āšĨāŧ‰āšēāš™
-8,73 āšĨāŧ‰āšēāš™
Other non operating income
886,00Â āšžāšąāš™
-703,00Â āšžāšąāš™
-47,00Â āšžāšąāš™
1,44 āšĨāŧ‰āšēāš™
EBT including unusual items
-46,98 āšĨāŧ‰āšēāš™
-1,58 āšĨāŧ‰āšēāš™
11,41 āšĨāŧ‰āšēāš™
-3,63 āšĨāŧ‰āšēāš™
EBT excluding unusual items
-14,55 āšĨāŧ‰āšēāš™
-1,58 āšĨāŧ‰āšēāš™
-5,05 āšĨāŧ‰āšēāš™
-3,63 āšĨāŧ‰āšēāš™
Income tax expense
6,19 āšĨāŧ‰āšēāš™
164,00Â āšžāšąāš™
-4,26 āšĨāŧ‰āšēāš™
403,00Â āšžāšąāš™
Effective tax rate
-13,18%
-10,39%
-37,29%
-11,10%
Other operating expenses
-
-
-
-
Net income
-51,47 āšĨāŧ‰āšēāš™
1,82 āšĨāŧ‰āšēāš™
-71,10 āšĨāŧ‰āšēāš™
-4,03 āšĨāŧ‰āšēāš™
Net profit margin
-56,96%
1,93%
-187,04%
-5,97%
Earnings per share
-
-
-
-
Interest and investment income
1,85 āšĨāŧ‰āšēāš™
991,00Â āšžāšąāš™
5,33 āšĨāŧ‰āšēāš™
1,24 āšĨāŧ‰āšēāš™
Interest expense
-2,22 āšĨāŧ‰āšēāš™
-2,11 āšĨāŧ‰āšēāš™
-
-464,00Â āšžāšąāš™
Net interest expenses
-374,00Â āšžāšąāš™
-1,12 āšĨāŧ‰āšēāš™
5,33 āšĨāŧ‰āšēāš™
777,00Â āšžāšąāš™
Depreciation and amortization charges
2,90 āšĨāŧ‰āšēāš™
2,62 āšĨāŧ‰āšēāš™
-3,42 āšĨāŧ‰āšēāš™
937,00Â āšžāšąāš™
EBITDA
-12,36 āšĨāŧ‰āšēāš™
8,58 āšĨāŧ‰āšēāš™
-6,60 āšĨāŧ‰āšēāš™
-4,77 āšĨāŧ‰āšēāš™
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
āŧāš­āšąāššāš‚āš­āš‡ Google